Randomized phase III study of Lipoplatin + paclitaxel versus cisplatin + paclitaxel as front line treatment of advanced epithelial ovarian cancer (EOC).
Phase of Trial: Phase III
Latest Information Update: 26 May 2011
At a glance
- Drugs Cisplatin; Paclitaxel
- Indications Ovarian cancer
- Focus Adverse reactions; Therapeutic Use
- 26 May 2011 New trial record